4
Changes in Ownership
Pacira BioSciences, Inc. Filed Acc 0001628280-26-074529
Director disposed of 20,136 shares (code U)
- Director returned 6,405 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Froimson Mark Director | 2026-11-17 | Other disposition | −20,136 | $36.50 | $734,964 | 6,405 | D: show line 1 in the form |
| Froimson Mark Director | 2026-11-17 | Returned to the company | −6,405 | $36.50 | $233,783 | 0 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Froimson Mark Director | 2026-11-17 | Returned to the company · Stock Option (Right to Buy) | −4,693 | $38.35 | 2028-06-13 | 4,693 | 0 | D: show line 3 in the form | ||
| Froimson Mark Director | 2026-11-17 | Returned to the company · Stock Option (Right to Buy) | −8,437 | $43.54 | 2029-06-05 | 8,437 | 0 | D: show line 4 in the form | ||
| Froimson Mark Director | 2026-11-17 | Returned to the company · Stock Option (Right to Buy) | −8,027 | $47.65 | 2030-06-09 | 8,027 | 0 | D: show line 5 in the form | ||
| Froimson Mark Director | 2026-11-17 | Returned to the company · Stock Option (Right to Buy) | −7,626 | $60.96 | 2031-06-09 | 7,626 | 0 | D: show line 6 in the form | ||
| Froimson Mark Director | 2026-11-17 | Returned to the company · Stock Option (Right to Buy) | −8,225 | $59.39 | 2032-06-08 | 8,225 | 0 | D: show line 7 in the form | ||
| Froimson Mark Director | 2026-11-17 | Returned to the company · Stock Option (Right to Buy) | −12,925 | $38.74 | 2033-06-14 | 12,925 | 0 | D: show line 8 in the form | ||
| Froimson Mark Director | 2026-11-17 | Returned to the company · Stock Option (Right to Buy) | −11,279 | $24.34 | 2035-06-11 | 11,279 | 0 | D: show line 9 in the form | ||
| Froimson Mark Director | 2026-11-17 | Returned to the company · Stock Option (Right to Buy) | −10,891 | $23.42 | 2036-06-10 | 10,891 | 0 | D: show line 10 in the form | ||
| Froimson Mark Director | 2026-11-17 | Returned to the company · Stock Option (Right to Buy) | −8,144 | $44.20 | 2027-06-14 | 8,144 | 0 | D: show line 11 in the form |
Loading xslF345X06/wk-form4_1794951381.xml…